Abstract |
Transoral and transcervical surgery to treat glottic cancer has advanced substantially over the past decade. There have been considerable innovations that enhance vocal function for early disease and airway function for advanced disease. The fiber-based angiolytic 532 nm potassium titanyl phosphate laser has provided a new foundational strategy to maintain high cure rates with enhanced vocal outcomes for the treatment of early glottic disease. For advanced glottic cancer, transplanting cryopreserved aortic homograft to reconstruct wide-field laryngotracheal airway defects can provide an adequate airway caliber such that a long-term tracheotomy can frequently be avoided.
|
Authors | Steven M Zeitels |
Journal | Otolaryngologic clinics of North America
(Otolaryngol Clin North Am)
Vol. 48
Issue 4
Pg. 677-85
(Aug 2015)
ISSN: 1557-8259 [Electronic] United States |
PMID | 26233792
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright © 2015 S. Zeitels. Published by Elsevier Inc. All rights reserved. |
Topics |
- Carcinoma, Squamous Cell
(pathology, surgery)
- Humans
- Laryngeal Neoplasms
(surgery)
- Laryngectomy
(methods)
- Laser Therapy
(methods)
- Lasers, Solid-State
(therapeutic use)
- Organ Sparing Treatments
(methods)
- Treatment Outcome
- Vocal Cords
(pathology)
- Voice Quality
|